Uloric and Papule - a phase IV clinical study of FDA data
Summary:
Papule is reported only by a few people who take Uloric.
The phase IV clinical study analyzes which people take Uloric and have Papule. It is created by eHealthMe based on reports of 7,483 people who have side effects while taking Uloric from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,483 people reported to have side effects when taking Uloric.
Among them, 2 people (0.03%) have Papule.
What is Uloric?
Uloric has active ingredients of febuxostat. It is often used in gout. eHealthMe is studying from 7,669 Uloric users for its effectiveness, alternative drugs and more.
What is Papule?
Papule is found to be associated with 1,050 drugs and 616 conditions by eHealthMe.
Number of Uloric and Papule reports submitted per year:

Gender of people who have Papule when taking Uloric *:
- female: 50 %
- male: 50 %
Age of people who have Papule when taking Uloric *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Uloric *:
- Valacyclovir: 1 person, 50.00%
- Revlimid: 1 person, 50.00%
- Ondansetron: 1 person, 50.00%
- Lactobacillus: 1 person, 50.00%
- Humira: 1 person, 50.00%
- Colcrys: 1 person, 50.00%
Common side effects people have besides Papule *:
- Tooth Disorder (tooth disease): 1 person, 50.00%
- Tooth Abscess (pus formation in tooth): 1 person, 50.00%
- Spinal Compression Fracture (fracture due to spinal compression on bone): 1 person, 50.00%
- Rashes (redness): 1 person, 50.00%
- Pain: 1 person, 50.00%
Common conditions people have *:
- Multiple Myeloma (cancer of the plasma cells): 1 person, 50.00%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Uloric and have Papule?
Check whether Papule is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Papule and when was it recovered:
Expand to all the drugs that have ingredients of febuxostat:
- Papule and drugs with ingredients of febuxostat (3 reports)
Alternative drugs to, pros and cons of Uloric:
- Uloric (7,669 reports)
Common Uloric side effects:
- Rashes (redness): 819 reports
- Drug ineffective: 679 reports
- Headache (pain in head): 632 reports
- Fatigue (feeling of tiredness): 530 reports
- Diarrhea: 511 reports
Browse all side effects of Uloric:
a b c d e f g h i j k l m n o p q r s t u v w x y zPapule treatments and more:
- Papule (5,183 reports)
COVID vaccines that are related to Papule:
- Papule in Moderna COVID Vaccine
- Papule in Pfizer BioNTech Covid Vaccine
- Papule in Johnson and Johnson Covid Vaccine
Common drugs associated with Papule:
- Humira: 475 reports
- Enbrel: 328 reports
- Prednisone: 306 reports
- Methotrexate: 244 reports
- Revlimid: 227 reports
- Aspirin: 195 reports
- Amlodipine: 156 reports
- Omeprazole: 154 reports
- Xolair: 139 reports
- Prednisolone: 130 reports
All the drugs that are associated with Papule:
- Papule (1,050 drugs)
Common conditions associated with Papule:
- Rheumatoid arthritis: 367 reports
- Psoriasis: 303 reports
- High blood pressure: 264 reports
- Multiple myeloma: 250 reports
- Crohn's disease: 158 reports
- High blood cholesterol: 131 reports
- Osteoporosis: 124 reports
All the conditions that are associated with Papule:
- Papule (616 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on febuxostat (the active ingredients of Uloric) and Uloric (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Procardia Xl and Acute Myeloid Leukaemia Aggravated - 6 seconds ago
- Imuran and Diabetic Nephropathy - 24 seconds ago
- Profen and Coronary Arterial Stent Insertion - 26 seconds ago
- Lyrica and Coordination Abnormal - 27 seconds ago
- Bepotastine Besilate and Blood Lactate Dehydrogenase Increased - 32 seconds ago
- Stendra and Tremor - 34 seconds ago
- Norditropin and Complex Regional Pain Syndrome - 38 seconds ago
- Rabeprazole and Sinus Rhythm - 39 seconds ago
- Dronabinol and Dysuria Aggravated - 53 seconds ago
- Artane and Nausea And Vomiting - a minute ago